✦ LIBER ✦

Immunogenicity and serotype-specific efficacy of a 9-valent pneumococcal conjugate vaccine (PCV-9) determined during an efficacy trial in The Gambia

✍ Scribed by M. Saaka; B.J. Okoko; R.C. Kohberger; S. Jaffar; G. Enwere; E.E. Biney; C. Oluwalana; A. Vaughan; S.M.A. Zaman; L. Asthon; D. Goldblatt; B.M. Greenwood; F.T. Cutts; R.A. Adegbola

Book ID: 116960571
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 500 KB
Volume: 26
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2008.04.066

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of nine-valent pneumococcal con

Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial

✍ FT Cutts; SMA Zaman; G Enwere; S Jaffar; OS Levine; JB Okoko; C Oluwalana; A Vau 📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 107 KB

Long-term immunogenicity and efficacy of

Long-term immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in human immunodeficient virus infected and non-infected children in the absence of a booster dose of vaccine

✍ Shabir A. Madhi; Peter Adrian; Locadiah Kuwanda; Wasilla Jassat; Stephanie Jones 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 125 KB